SXTC Live signals | Maximize Profits with Getagraph.com

SELL 100334 min ago

@ $2.15

Issued: 14 Feb 2024 @ 13:52

Return: -50.23%

Previous signal: Feb 14 - 09:31

Previous signal: Buy

Return: 13.46 %

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China...

Stats
Today's Volume	429 082
Average Volume	1.26M
Market Cap	11.18M
EPS	$0 ( 2023-10-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.540
ATR14	$0.0140 (1.30%)

Volume Correlation

Long: -0.25 (neutral)

Short: -0.74 (moderate negative)

Signal:(42.799) Neutral

China SXT Pharmaceuticals Correlation

10 Most Positive Correlations
SIRI	0.87
LSXMA	0.856
LSXMK	0.854
CVBF	0.846
MCMJ	0.846
BMRC	0.839
TVACW	0.838
BSRR	0.838
FGBI	0.838
ESSA	0.837

10 Most Negative Correlations
BLPH	-0.864
INTA	-0.861
MLTX	-0.846
MNDY	-0.838
FSLR	-0.838
LRMR	-0.83
DUOL	-0.828
RIVE	-0.828
DSEY	-0.828
PLYA	-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China SXT Pharmaceuticals Correlation - Currency/Commodity

0.03
( neutral )

0.01
( neutral )

0.00
( neutral )

0.78
( moderate )

0.15
( neutral )

China SXT Pharmaceuticals Financials

Annual	2023
Revenue:	$1.97M
Gross Profit:	$426 271 (21.62 %)
EPS:	$-5.71

Q2	2024
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q4	2023
Revenue:	$763 391
Gross Profit:	$336 587 (44.09 %)
EPS:	$-0.390

Q3	2023
Revenue:	$381 696
Gross Profit:	$168 294 (44.09 %)
EPS:	$-5.14

Financial Reports:

No articles found.

China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.